Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancer Treatment Reviews|April 17, 2007
Biochemical markers in oncology. Part I: molecular basis. Part II: clinical usesN Voorzanger-Rousselot, P GarneroBlood|October 27, 1998
Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cellsN Voorzanger-Rousselot, M Favrot, J Y BlayBritish Journal of Cancer|August 2, 2006
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluationN Voorzanger-Rousselot, F Juillet, E Mareau, et al.British Journal of Cancer|September 19, 2007
Increased Dickkopf-1 expression in breast cancer bone metastasesN Voorzanger-Rousselot, D Goehrig, F Journe, et al.British Journal of Cancer|September 15, 2001
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicityC M Galmarini, N Falette, E Tabone, et al.Pageof 1